Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

“Treatment with curative intent”: the emergence of genetic therapies for sickle cell anemia

Edward J. Benz, Jr., Leslie E. Silberstein, Julie Panepinto

Blood (2024) 143 (11): 967–970.

https://doi.org/10.1182/blood.2023021598

Published: 2024

Journal Articles

COVID-19 Outcomes in Individuals with Sickle Cell Disease and Sickle Cell Trait Compared to Blacks without Sickle Cell Disease or Trait

Ashima Singh, PhDMS, Amanda M. Brandow, DO, MS, Julie Panepinto, MDMS

Blood (2020) 136 (Supplement 1): 54–56.

https://doi.org/10.1182/blood-2020-136763

Published: 2020

Journal Articles

Plasma-Based Inflammatory Signatures in Patients with Sickle Cell Disease during Baseline Health and Acute Pain

Lana Mucalo, MD, Shuang Jia, MS, Julie Panepinto, MDMS, Mark F. Roethle, MS, Martin J. Hessner, PhD, Amanda M. Brandow, DO, MS

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-140025

Published: 2020

Journal Articles

Hospitalization and Case Fatality in Individuals with Sickle Cell Disease and COVID-19 Infection

Lana Mucalo, MD, Amanda M. Brandow, DO, MS, Sadie F. Mason, MD, Ashima Singh, PhDMS, Bradley W. Taylor, FAMIA, Katherine J. Woods, MS, Fouza I. Yusuf, MS, MPH, Julie Panepinto, MDMS

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-137676

Published: 2020

Journal Articles

Neuropathic Pain Is Associated with Poor Health-Related Quality of Life in Adolescents with Sickle Cell Disease

Marisa Roman, BA, Janelle Highland, MA, MPP, Dawn Retherford, Amy Pan, PhD, Julie Panepinto, MDMSPH, Amanda M. Brandow, DO, MS

Blood (2019) 134 (Supplement_1): 417.

https://doi.org/10.1182/blood-2019-127626

Published: 2019

Journal Articles

Real-Time Electronic Health Registry Improves Care for Children with Sickle Cell Disease

Ashima Singh, PhD MS, Vanaja Danda, Julie Panepinto, MDMSPH

Blood (2019) 134 (Supplement_1): 4673.

https://doi.org/10.1182/blood-2019-123780

Published: 2019

Journal Articles

Comparison of Health Outcomes in Adolescent and Young Adults (AYA) Oncology Patients Treated at a Pediatric Versus Adult Institute

Amy Moskop, MD, Ke Yan, PhD, Sarah K. Dobrozsi, MD, Julie Panepinto, MDMSPH

Blood (2019) 134 (Supplement_1): 4743.

https://doi.org/10.1182/blood-2019-121616

Published: 2019

Journal Articles

Impact of Residual Effects and Complications of Thrombotic Thrombocytopenic Purpura (TTP) on Daily Living: A Qualitative Study

Deirdra Terrell, PhD, Spero Cataland, MD, Laura Beebe, PhD, San Keller, PhD MS, Julie Panepinto, MDMSPH, Sara K. Vesely, PhD MPH, James George, MD, Rachel Ann Kelley, BS, Marshall Cheney, PhD

Blood (2019) 134 (Supplement_1): 931.

https://doi.org/10.1182/blood-2019-128989

Published: 2019

Journal Articles

Clinical Meaning of Promis Pain Interference and Pain Behavior Measures for Children with Sickle Cell Disease

Ashima Singh, PhD MS, Julie Panepinto, MD MSPH

Blood (2018) 132 (Supplement 1): 161.

https://doi.org/10.1182/blood-2018-161

Published: 2018

Journal Articles

Cold and Mechanical Hypersensitivity Is Exacerbated during Acute Pain in Children and Adolescents with Sickle Cell Disease

Amanda M Brandow, DO, MS, Karla Hansen, Melodee Nugent, Amy Pan, Julie Panepinto

Blood (2017) 130 (Supplement 1): 2259.

https://doi.org/10.1182/blood.V130.Suppl_1.2259.2259

Published: 2017

Journal Articles

Using Project Echo Telementoring to Improve Sickle Cell Disease Care in the Midwest

Lisa Marie Shook, MA, MCHES, Christina Bennett Farrell, MPH, Karen A. Kalinyak, MD, Stephen C Nelson, MD, Brandon M. Hardesty, MD, Angeli Rampersad, MD, Kay Linn Saving, MD, Wanda Witten-Shurney, Julie Panepinto, Trisha Calabrese, MPH, Lori E. Crosby, PsyD, Russell E. Ware, MD PhD

Blood (2016) 128 (22): 5923.

https://doi.org/10.1182/blood.V128.22.5923.5923

Published: 2016

Journal Articles

Desmopressin and Epsilon Amino-Caproic Acid (EACA) in Adenotonsillectomy (T & A): Are We Under-Treating Patients with Mild Type 1 von Willebrand Disease (VWD) and Mild Platelet Function Defects (PFD)?.

Joan Cox Gill, MD, Ronyanika Rowe, Stephen Conley, MD, Cheryl Hillery, MD, Julie Panepinto, MD, J. Paul Scott, MD, Robert R. Montgomery, MD

Blood (2004) 104 (11): 1024.

https://doi.org/10.1182/blood.V104.11.1024.1024

Published: 2004

NARROW

“Treatment with curative intent”: the emergence of genetic therapies for sickle cell anemia

COVID-19 Outcomes in Individuals with Sickle Cell Disease and Sickle Cell Trait Compared to Blacks without Sickle Cell Disease or Trait

Plasma-Based Inflammatory Signatures in Patients with Sickle Cell Disease during Baseline Health and Acute Pain

Hospitalization and Case Fatality in Individuals with Sickle Cell Disease and COVID-19 Infection

Neuropathic Pain Is Associated with Poor Health-Related Quality of Life in Adolescents with Sickle Cell Disease

Real-Time Electronic Health Registry Improves Care for Children with Sickle Cell Disease

Comparison of Health Outcomes in Adolescent and Young Adults (AYA) Oncology Patients Treated at a Pediatric Versus Adult Institute

Impact of Residual Effects and Complications of Thrombotic Thrombocytopenic Purpura (TTP) on Daily Living: A Qualitative Study

Clinical Meaning of Promis Pain Interference and Pain Behavior Measures for Children with Sickle Cell Disease

Cold and Mechanical Hypersensitivity Is Exacerbated during Acute Pain in Children and Adolescents with Sickle Cell Disease

Using Project Echo Telementoring to Improve Sickle Cell Disease Care in the Midwest

Desmopressin and Epsilon Amino-Caproic Acid (EACA) in Adenotonsillectomy (T & A): Are We Under-Treating Patients with Mild Type 1 von Willebrand Disease (VWD) and Mild Platelet Function Defects (PFD)?.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only